Mutsa Bwakura-Dangarembizi
Tracked across 1 events · 6 articles · First seen Sep 20, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
A clinical trial led by University College London found that long-acting HIV injections given every eight weeks kept the virus suppressed more effectively than daily antiretroviral tablets among adolescents. The LATA (Long-Acting Treatment in Adolescents)…
Impact: Dr Mutsa Bwakura-Dangarembizi was the trial physician and principal investigator of the Harare site, calling for action to make injectables available in Africa.
Sep 20, 2026 · 6 articles
25
Mutsa Bwakura-Dangarembizi called for availabilityLATA Trial: HIV Injections...
ERGEN INTELLIGENCE
Track Mutsa Bwakura-Dangarembizi live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard